Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyAppropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

An update from the original ASCO guideline on this topic published in 2012, 60 studies, primarily retrospective, were included in the review. New to this version of the guideline, the Panel offers recommendations on approved doses of immunotherapy and targeted therapies that can be offered to obese patients with cancer.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form